Author:
Perolla Adela,Çalliku Elsuarta,Cili Alma,Caja Tatjana,Pulluqi Polikron,Ivanaj Arben
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Public Law 107 - 280 - Rare Diseases Act of 2002. (2023). Accessed. January 11, 2024: https://www.govinfo.gov/app/details/PLAW-107publ280.
2. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. (2000). Accessed. November 13, 2023: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF.
3. {BLR 1412} FDA - Orphan Drug - ABC - PMA. (1993). Accessed. November 13, 2023: https://www.liebertpub.com/doi/10.1089/blr.1993.12.13.
4. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35 countries;Gammie T;PLoS One,2015
5. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database;Nguengang Wakap S;Eur J Hum Genet,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献